Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03XCR
|
||||
Former ID |
DIB005909
|
||||
Drug Name |
Simotaxel
|
||||
Synonyms |
MST-997; TL-909
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [521789] | ||
Company |
Taxolog Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C46H57NO15S
|
||||
Canonical SMILES |
[C@@H]1(OC(=O)C2CCCC2)C2=C([C@H](C[C@](C2(C)C)([C@H]([C<br />@H]2[C@](C1=O)([C@H](C[C@@H]1[C@]2(CO1)OC(=O)C)O)C)OC(=<br />O)c1ccccc1)O)OC(=O)[C@@H]([C@@H](NC(=O)OC(C)C)c1sccc1)O<br />)C
|
||||
CAS Number |
CAS 791635-59-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Inhibitor | [543674] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.